Advertisement
U.S. markets open in 5 hours 18 minutes
Advertisement

SenesTech, Inc. (SNES)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.9600+0.0300 (+3.23%)
At close: 04:00PM EST
0.9547 -0.01 (-0.55%)
After hours: 07:57PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Gap Down

Gap Down

Previous Close0.9300
Open1.0000
Bid0.0000 x 1000
Ask0.0000 x 800
Day's Range0.8910 - 1.0000
52 Week Range0.8710 - 80.9520
Volume275,590
Avg. Volume165,141
Market Cap3.983M
Beta (5Y Monthly)1.22
PE Ratio (TTM)0.00
EPS (TTM)2,307.6001
Earnings DateNov 09, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SNES

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • SenesTech, Inc.
    Analyst Report: ICON Public Limited CompanyIcon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
    Rating
    Fair Value
    Economic Moat
    last monthMorningstar
View more
  • PR Newswire

    SenesTech, Inc. Announces Closing of $5.0 Million Public Offering

    SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com), the leader in fertility control to manage animal pest populations, today announced the closing of its previously announced public offering of 3,846,154 shares of its common stock (or pre-funded warrants in lieu thereof) and accompanying Series D warrants to purchase up to 3,846,154 shares of its common stock ("Series D Warrants") and Series E warrants to purchase up to 3,846,154 shares of its common stock ("Series

  • PR Newswire

    SenesTech, Inc. Announces Pricing of $5.0 Million Public Offering

    SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced the pricing of a public offering of 3,846,154 shares of its common stock (or pre-funded warrants in lieu thereof) and accompanying Series D warrants to purchase up to 3,846,154 shares of its common stock ("Series D Warrants") and Series E warrants to purchase up to 3,846,154 shares of its common stock ("Series E Warrants", together w

  • PR Newswire

    SenesTech Launches EVOLVE Soft Bait Fertility Solution in California-based Ace Hardware Franchise Locations

    SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the leader in fertility control to manage animal pest populations, today announced the launch of Evolve™ Soft Bait ("Evolve") at Ace Hardware franchise locations in California. Evolve is the first and only soft bait product featuring breakthrough, next generation technology that targets rodent populations by using nonlethal methods to restrict fertility. The franchise has also recently began selling SenesTech's exp